Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lorna Wall"'
Autor:
Nicole Thornton, Vanja Karamatic Crew, Louise Tilley, Carole A. Green, Chwen Ling Tay, Rebecca E. Griffiths, Belinda K. Singleton, Frances Spring, Piers Walser, Abdul Ghani Alattar, Benjamin Jones, Rosalind Laundy, Jill R. Storry, Mattias Möller, Lorna Wall, Richard Charlewood, Connie M. Westhoff, Christine Lomas-Francis, Vered Yahalom, Ute Feick, Axel Seltsam, Beate Mayer, Martin L. Olsson, David J. Anstee
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-11 (2020)
The molecular basis of the clinically important MAM blood group antigen present in most humans is unknown. We identify EMP3 as its encoding gene, establishing MAM as a new blood group system, and demonstrate the role of EMP3 in erythropoiesis through
Externí odkaz:
https://doaj.org/article/e938a7d9bc5f42fa84a3d130a0d92402
Autor:
Beate Mayer, Vanja Karamatic Crew, Louise Tilley, Richard Charlewood, Chwen Ling Tay, Vered Yahalom, D J Anstee, Belinda K. Singleton, Abdul Ghani Alattar, Ute Feick, Axel Seltsam, Nicole Thornton, Jill R. Storry, C A Green, Frances A. Spring, Benjamin Jones, Rebecca E. Griffiths, Rosalind Laundy, Piers Walser, Connie M. Westhoff, Mattias Möller, Christine Lomas-Francis, Lorna Wall, Martin L. Olsson
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-11 (2020)
Nature Communications
Nature Communications
The clinically important MAM blood group antigen is present on haematopoietic cells of all humans except rare MAM-negative individuals. Its molecular basis is unknown. By whole-exome sequencing we identify EMP3, encoding epithelial membrane protein 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52a4ccac09c8e060f2829dbf36452cfd
http://link.springer.com/article/10.1038/s41467-020-17060-4
http://link.springer.com/article/10.1038/s41467-020-17060-4
Autor:
D. Gounder, M. A. de Brito, K. Barotine-Toth, C. C. Folman, S. Wendel, J. Matilainen, Vered Yahalom, H. Hustinx, Pertti Sistonen, M. de Haas, Orna Asher, Geralyn M. Meny, Maria Antonietta Villa, P.Y. Le Pennec, Rita Fontão-Wendel, Harald Schennach, S. R. Joshi, W. C. Tsoi, K. Vasantha, I. von Zabern, Peter Flanagan, M. M. W. Koopman, C. P. Engelfriet, Maurizio Marconi, Christoph Niederhauser, Erik A M Beckers, I. Hoffer, C. K. Lin, Nicoletta Revelli, N. Greppi, Cyril Levene, Christoph Gassner, E. Aranburu Urtasun, Lorna Wall, Henk W. Reesink, Philippe Rouger, Willy A. Flegel, Bach-Nga Pham, Sandra Nance, Yoshihiko Tani, T. Peyrard, C. Flickinger
Publikováno v:
Vox sanguinis, 95(3), 236-253. Wiley-Blackwell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d7da77e4a2050c3be822dc5acec9c92
https://doi.org/10.1111/j.1423-0410.2008.01084.x
https://doi.org/10.1111/j.1423-0410.2008.01084.x
Autor:
Licia Capra, Sarah Gallacher, Sami Andberg, Lisa Koeman, Yvonne Rogers, Lorna Wall, Connie Golsteijn
Publikováno v:
UbiComp
Organizers regularly want to understand the experiences of event goers and typically use survey methods, with researchers and clipboards. However, gathering opinions in such ways is difficult to do without disrupting the event goers' experience. In p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7cb0f4ff95a8fc24450703198360ab3
https://doi.org/10.1145/2750858.2807529
https://doi.org/10.1145/2750858.2807529
Autor:
Claudia I Chapuy, Maria D Aguad, Rachel T Nicholson, James P AuBuchon, Claudia S Cohn, Meghan Delaney, Joan Cid, Walter Dzik, Mark K. Fung, Andreas Greinacher, Ai Leen Ang, Dana V. Devine, Nancy M Dunbar, Henk Garritsen, Lawrence T Goodnough, Ross Herron, Tor A. Hervig, C. Michael Knudson, Jose M Kutner, Frank Nizzi, Suchitra Pandey, Benjamin Rioux-Masse, Kathleen Selleng, Joseph Sweeney, Minoko Takanashi, Aaron A.R. Tobian, Lorna Wall, Silvano Wendel, David A Westerman, Meredith Unger, Parul Doshi, Michael F. Murphy, Larry J. Dumont, Richard M. Kaufman, The BEST Collaborative
Publikováno v:
Blood. 126:3567-3567
Introduction Daratumumab (DARA), an IgG1k human monoclonal antibody (Ab) against CD38, is a promising novel therapy for multiple myeloma. However, direct binding of DARA to endogenous CD38 on reagent red blood cells (RBCs) interferes with routine blo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a01c6193b034e97335e5b8741e4706e2
https://doi.org/10.1182/blood.v126.23.3567.3567
https://doi.org/10.1182/blood.v126.23.3567.3567